
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
HISTORICAL BACKGROUND OF CANNABIS SATIVA: A REVIEW
Vishal Bhosale*, Swapnil Shinde, Vaibhav Bhosale and Akanksha Shinde
Abstract Plant have every time been common source of medicament. Either the form of conventional preparation or as pure lively principle. These cannabis plant (cannabis sativa L.) have a large history as recreational drug. But is as well as part of traditional medicine in a several culture. The product of cannabis plant such as (marijuana, hashish, and hash oil) have a large history of use as both medicinal agent and intoxicant. Above the last some years there have a been active debate as regards the medicinal aspects of cannabis. It is contain approximately 60 different cannabinoid counting tetrahydrocannabinol (THC, dronbinol) cannabinol, cannabidiol and cannbigerol, cannabichromene. It is a therapeutic potential is calm in the district of muscle relaxation and cannabinoids are presently for the use of treatment of a anorexia, bronchia, asthma, ellipsy, glaucoma, hypertension and vomiting. There are a two cannabinoids presently licensed for medicinal use. The first is THC (Marinol) is build synthetically and licensed in a USA for a treatment of a nausea following cancer chemotherapy and a appetite enhancement in suffering with AIDS. The second is nabilone, is a complete synthetically derived cannabinoid. It is a licensed in UK for the treat of nausea known as chemotherapy. As a third synthetic cannabinoid, dexanabinol is the phase of 3 clinical trials. Keywords: . [Full Text Article] [Download Certificate] |
